[α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy].

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.17116/jnevro20171173150-55PMID 28399096
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.

  2015cited by this paper
• Efficacy of α-lipoic acid in diabetic neuropathy

  2014cited by this paper
• Alpha lipoic acid and glycaemic control in diabetic neuropathies at type 2 diabetes treatment.

  2013cited by this paper
• CLONAZEPAM FOR NEUROPATHIC PAIN AND FIBROMYALGIA IN ADULTS

  2012cited by this paper
• Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials

  2012cited by this paper
• ENHANCED GLUCOSE CONTROL FOR PREVENTING AND TREATING DIABETIC NEUROPATHY

  2012cited by this paper
• Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

  2010cited by this paper
• Global estimates of the prevalence of diabetes for 2010 and 2030.

  2010cited by this paper
• Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

  2010cited by this paper
• Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes?

  2010cited by this paper
• Molecular Mechanisms of Lipoic Acid Modulation of T-Type Calcium Channels in Pain Pathway

  2009cited by this paper
• Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.

  2009cited by this paper
• Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy

  2006influential reference
• Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.

  2004cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Thioctic Acid for Patients with Symptomatic Diabetic Polyneuropathy

  2004cited by this paper
• Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

  2003cited by this paper
• Molecular motors

  2003cited by this paper
• Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control study

  2003cited by this paper
• The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid

  2003cited by this paper
• The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

  2003cited by this paper
• Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.

  2000cited by this paper
• alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria.

  1999cited by this paper
• Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy

  1999cited by this paper
• Insufficient Glycemic Control Increases Nuclear Factor-κB Binding Activity in Peripheral Blood Mononuclear Cells Isolated From Patients With Type 1 Diabetes

  1998cited by this paper
• Metabolic and Vascular Factors in the Pathogenesis of Diabetic Neuropathy

  1997cited by this paper
• Lipoic Acid Improves Nerve Blood Flow, Reduces Oxidative Stress, and Improves Distal Nerve Conduction in Experimental Diabetic Neuropathy

  1995cited by this paper
• Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).

  1995cited by this paper
• alpha-Lipoic acid as a biological antioxidant.

  1995cited by this paper

• Radiculopathy in diabetic polyneuropathy patients: difficulties in the diagnosis and therapy

  2022cites this paper
• Lipoic Acid Decreases the Expression of Poly ADP-Ribose Polymerase and Inhibits Apoptosis in Diabetic Rats

  2020cites this paper
• Сlinical Practice of Ipidacrinum Application in Tunnel Neuropathy

  2020cites this paper
• DMSO_A_241678 1725..1731

  2020cites this paper
• Effect of lipoic acid on the exchange of sialo-containing compounds in rats blood plasma with alloxan diabet

  2018cites this paper